Author correction to‘Co-delivery of nigericin and decitabine using hexahistidine-metal nanocarriers for pyroptosis-induced immunotherapeutics’[Acta Pharm Sin B 12(2022)4458–4471]  

作　　者：Qiang Niu Yu Liu Yujing Zheng Ziwei Tang Yuna Qian Ruogu Qi Jianliang Shen Ping Zhao 

机构地区：[1]School of Chemistry and Chemical Engineering,Guangdong Pharmaceutical University,Guangzhou 510006,China [2]State Key Laboratory of Ophthalmology,Optometry and Vision Science,School of Ophthalmology and Optometry,School of Biomedical Engineering,Wenzhou Medical University,Wenzhou 325027,China [3]Wenzhou Institute,University of Chinese Academy of Sciences,Wenzhou 325001,China [4]School of Medicine&Holistic Integrative Medicine,Nanjing University of Chinese Medicine,Nanjing 210023,China

出　　处：《Acta Pharmaceutica Sinica B》2024年第5期2359-2360,共2页药学学报（英文版）

摘　　要：The authors regret that there is an error in Fig.6 in the article due to the mistake of copying and pasting in the process of assemblingfigures and negligence in the proofreading.Although it does not affect the conclusion,it is an obvious error.The authors have now modified as below.The authors apologize for any inconvenience caused to the journal and readers.

关 键 词：journal CORRECTION conclusion 

分 类 号：R730.51[医药卫生—肿瘤] G23[医药卫生—临床医学]